Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T71969 |
Remacemide
|
||
Remacemide is a low-affinity NMDA antagonist with sodium channel blocking properties. It has been studied for the treatment of acute ischemic stroke, epilepsy, Huntington's disease, and Parkinson's disease. | |||
T23231 |
Remacemide hydrochloride
|
Others | Others |
Remacemide hydrochloride is a NMDA receptor antagonist. | |||
T71058 |
Doramapimod HCl
|
||
Doramapimod HCl is the salt form of Doramapimod, a member of the N-pyrazole-N'-naphthly urea class of p38MAPK inhibitors, which binds to the kinase with both slow association and dissociation rates. BIRB -796 has entered clinical trials for the treatment of autoimmune diseases. | |||
T50052 |
1,2-diphenylpropan-2-amine
|
Others | Others |
1,2-diphenylpropan-2-amine 是Remacemide 的(S,R)-异构体单盐酸盐代谢产物。1,2-diphenylpropan-2-amine 具有抗惊厥作用。 |